RESUMO
Background. Technetium-99m-mercaptoacetyltriglycine (99-mTc-MAG3) is a radiopharmaceutical for tubular function and can be prepared with 99-mtechnetium and the ligand Bz-MAG3 (Instituto Nacional de Investigaciones Nucleares, Mexico City). No radiopharmacokinetic parameters have been found for the healty adult Mexican population with 99mTc-MAG3, prepared with the nationally produced or imported Bz-MAG3 kit. Methods. The radiopharmacokinetic parametrs and the clearance of 99mTc-Mag3 in seven healthy Mexican volunteers were determined by the single-and multi-sample methods. Computer programs were used for the calculations. Results. Using several plasma samples from 0.43 min and the BIEXP program, it was show that 99mTc-MAG3 follows a two-compartment model of distribution, with an apparent volumen in the central compartment Vdcc = 6.7 + 1.0 1, T½Ó = 0.07 + 0.02 h-1, T½ ß = 0.49 + 0.15 h-1, mean residence time MRT = 0.60 + 0.17 h and clearance = 208 57 (ml/min)/1.73 m². In comparison, the clearance value with a single sample drawn 43 min post-injection and calculated with Tauxe's formula was 193 ñ 59 (ml/min)/m². Conclusions. The 15 ml difference between the two methods is neither statistically different (p= 0.11) nor important for routine clinical studies. The single-sample method is recommendad because it is reliable and can be done at the same time that dynamic renal scan is aquiered. Estimated absorbed radiation dose was calvulated for several organs
